Trial Profile
Efficacy of Atomoxetine in Adults With ADHD and Substance Abuse Disorder Being Treated in a Residential Treatment Facility.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 May 2019
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 28 Oct 2011 Additional location (USA) added as reported by ClinicalTrials.gov.
- 18 Aug 2009 New trial record